Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Breast Cancer”

672 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 672 results

Not applicableNot Yet RecruitingNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT04588935
What this trial is testing

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

Who this might be right for
Women With Breast Cancer
State Institution "Republican Scientific and Practical Center" Cardiology, Belarus 100
Testing effectiveness (Phase 2)UnknownNCT03634501
What this trial is testing

Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells

Who this might be right for
Lung CancerBreast CancerColon Cancer+2 more
Xuanwu Hospital, Beijing 200
Testing effectiveness (Phase 2)Study completedNCT00548899
What this trial is testing

Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 36
Early research (Phase 1)Study completedNCT04456140
What this trial is testing

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Who this might be right for
Breast CarcinomaDigestive System NeoplasmMalignant Brain Neoplasm+8 more
Mayo Clinic 230
Not applicableStudy completedNCT04058418
What this trial is testing

Specialist Recommendation on FBC (Familial Breast Cancer) Chemoprevention Prescribing

Who this might be right for
Familial Breast Cancer
University of Nottingham 50
Not applicableStudy completedNCT02512835
What this trial is testing

Understanding the Value of Community Vital Signs in Primary Care

Who this might be right for
Colon CancerBreast CancerCervical Cancer+2 more
Virginia Commonwealth University 120
Large-scale testing (Phase 3)Study completedNCT00003140
What this trial is testing

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 5,187
Not applicableStudy completedNCT01942759
What this trial is testing

The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer

Who this might be right for
Breast Neoplasms
Bagcilar Training and Research Hospital 43
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Early research (Phase 1)Study completedNCT03790423
What this trial is testing

18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+2 more
Rigshospitalet, Denmark 10
Testing effectiveness (Phase 2)Study completedNCT00247650
What this trial is testing

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Novartis 190
Testing effectiveness (Phase 2)Study completedNCT01593020
What this trial is testing

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Study completedNCT02357927
What this trial is testing

A Single Session Intervention For Fear Of Recurrence In Breast Cancer Patients

Who this might be right for
Fear
University of St Andrews 16
Large-scale testing (Phase 3)Study completedNCT00639210
What this trial is testing

BREAST CANCER AND EXERCISE

Who this might be right for
Prevent Osteoporosis and Osteoporotic FracturesImprove Quality of LifeImprove Weight Control, and Muscular and Cardiovascular Fitness+3 more
Finnish Breast Cancer Group 573
Large-scale testing (Phase 3)Study completedNCT01864746
What this trial is testing

Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

Who this might be right for
Breast CancerHormonreceptor PositiveHer2-normal+2 more
GBG Forschungs GmbH 1,250
Testing effectiveness (Phase 2)Study completedNCT01204242
What this trial is testing

IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:

Who this might be right for
Breast Cancer
University of Virginia 78
Not applicableNot Yet RecruitingNCT06937281
What this trial is testing

SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors

Who this might be right for
Breast CancerMetastases
British Columbia Cancer Agency 40
Load More Results